Quaking and miR-155 interactions in inflammation and leukemogenesis

Quaking (QKI) is a tumor-suppressor gene encoding a conserved RNA-binding protein, whose expression is downregulated in several solid tumors. Here we report that QKI plays an important role in the immune response and suppression of leukemogenesis. We show that the expression of Qki is reduced in lipopolysaccharide (LPS)-challenged macrophages, suggesting that Qki is a key regulator of LPS signaling pathway. Furthermore, LPS-induced downregulation of Qki expression is miR-155-dependent. Qki overexpression impairs LPS-induced phosphorylation of JNK and particularly p38 MAPKs, in addition to increasing the production of anti-inflammatory cytokine IL-10. In contrast, Qki ablation decreases Fas expression and the rate of Caspase3/7 activity, while increasing the levels of IL-1α, IL-1β and IL-6, and p38 phosphorylation. Similarly, the p38 pathway is also a target of QKI activity in chronic lymphocytic leukemia (CLL)-derived MEC2 cells. Finally, B-CLL patients show lower levels of QKI expression compared with B cells from healthy donor, and Qki is similarily downregulated with the progression of leukemia in Eμ-miR-155 transgenic mice. Altogether, these data implicate QKI in the pathophysiology of inflammation and oncogenesis where miR-155 is involved.

[1]  E. Flemington,et al.  miR-155 induced transcriptome changes in the MCF-7 breast cancer cell line leads to enhanced mitogen activated protein kinase signaling , 2014, Genes & cancer.

[2]  S. Ludwin,et al.  miR‐155 as a multiple sclerosis–relevant regulator of myeloid cell polarization , 2013, Annals of neurology.

[3]  Timothy A. Miller,et al.  Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. , 2013, Human molecular genetics.

[4]  G. Calin,et al.  Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. , 2013, Blood.

[5]  J. Arthur,et al.  Mitogen-activated protein kinases in innate immunity , 2013, Nature Reviews Immunology.

[6]  Guido Marcucci,et al.  Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  G. Calin,et al.  Signal Transducer and Activator of Transcription–3 Induces MicroRNA-155 Expression in Chronic Lymphocytic Leukemia , 2013, PloS one.

[8]  C. Croce,et al.  MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer , 2013, Immunological reviews.

[9]  E. Vigorito,et al.  miR‐155: an ancient regulator of the immune system , 2013, Immunological reviews.

[10]  Valeria Mezzolla,et al.  Potential of Anti‐Cancer Therapy Based on Anti‐miR‐155 Oligonucleotides in Glioma and Brain Tumours , 2013, Chemical biology & drug design.

[11]  C. Croce,et al.  The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. , 2012, Blood.

[12]  Shizuo Akira,et al.  Dissecting negative regulation of Toll-like receptor signaling. , 2012, Trends in immunology.

[13]  S. Marsigliante,et al.  miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors. , 2012, International journal of oncology.

[14]  Yonghong Xiao,et al.  STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA. , 2012, Genes & development.

[15]  Christopher J. Cheng,et al.  Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma , 2012, Proceedings of the National Academy of Sciences.

[16]  Christian Ehlting,et al.  The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis. , 2012, Cellular signalling.

[17]  Jianyong Sun,et al.  Downregulation of tumor suppressor QKI in gastric cancer and its implication in cancer prognosis. , 2012, Biochemical and biophysical research communications.

[18]  Guodong Yang,et al.  The RNA-binding protein QKI5 is a direct target of C/EBPα and delays macrophage differentiation. , 2012, Molecular biology of the cell.

[19]  Guanghui Wang,et al.  miR-574-5p negatively regulates Qki6/7 to impact β-catenin/Wnt signalling and the development of colorectal cancer , 2012, Gut.

[20]  George A. Calin,et al.  GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGFβ effectors, Drosha and microRNAs with opposite oncogenic potentials , 2010, Nucleic acids research.

[21]  Susan R. Quinn,et al.  IL-10 Inhibits miR-155 Induction by Toll-like Receptors* , 2010, The Journal of Biological Chemistry.

[22]  D. Iliopoulos,et al.  The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. , 2009, Immunity.

[23]  C. Croce,et al.  Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. , 2009, Blood.

[24]  C. Hother,et al.  Onco-miR-155 targets SHIP1 to promote TNFα-dependent growth of B cell lymphomas , 2009, EMBO molecular medicine.

[25]  Ryan M. O’Connell,et al.  Inositol phosphatase SHIP1 is a primary target of miR-155 , 2009, Proceedings of the National Academy of Sciences.

[26]  Manuel A. S. Santos,et al.  MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells , 2009, Proceedings of the National Academy of Sciences.

[27]  C. Croce,et al.  miR-155: On the Crosstalk Between Inflammation and Cancer , 2009, International reviews of immunology.

[28]  P. Sharp,et al.  Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites , 2008, Science.

[29]  Muller Fabbri,et al.  Modulation of miR-155 and miR-125b Levels following Lipopolysaccharide/TNF-α Stimulation and Their Possible Roles in Regulating the Response to Endotoxin Shock1 , 2007, The Journal of Immunology.

[30]  David Baltimore,et al.  MicroRNA-155 is induced during the macrophage inflammatory response , 2007, Proceedings of the National Academy of Sciences.

[31]  E. Haralambieva,et al.  Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. , 2005 .

[32]  Muller Fabbri,et al.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.

[33]  S. Richard,et al.  Target RNA motif and target mRNAs of the Quaking STAR protein , 2005, Nature Structural &Molecular Biology.

[34]  S. Richard,et al.  QUAKING KH Domain Proteins as Regulators of Glial Cell Fate and Myelination , 2005, RNA biology.

[35]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[36]  Charles A. Janeway,et al.  IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.

[37]  S. Richard,et al.  Nuclear translocation controlled by alternatively spliced isoforms inactivates the QUAKING apoptotic inducer. , 2001, Genes & development.

[38]  M. Besson,et al.  The quaking mouse: an epileptic mutant with alterations affecting the modulatory mechanisms of the NMDA receptor complex , 1991, Brain Research.

[39]  Yue Feng,et al.  The star family member QKI and cell signaling. , 2010, Advances in experimental medicine and biology.

[40]  Guodong Yang,et al.  RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer. , 2010, Gastroenterology.

[41]  H. Taubert,et al.  Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival , 2010, International journal of cancer.

[42]  Yue Feng,et al.  The Star Family Member , 2010 .

[43]  Stefano Volinia,et al.  Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Jiahuai Han,et al.  Essential role of p38gamma in K-Ras transformation independent of phosphorylation. , 2005, The Journal of biological chemistry.